Skip to content
Home/Companies/Biotech/Allogenica
Allogenica

Allogenica

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Allogenica?

Allogenica is currently owned by Aloe Private Equity through Sorbonne Venture (2022 vintage), since 2022.

Hand-verified · updated 2026-07-07

Aloe Private Equity
Investor
Aloe Private Equity
Sorbonne Venture · 2022 · VC

Key facts

HQFrance
SectorBiotech
StatusActive
Websitewww.allogenica.com

More from Sorbonne Venture

Other portfolio companies in the same fund.

DiogenX
Active
O-Kidia
Active
Austral DX
Austral DX
Active
MedTechFrance· 2025
EVerZom
Active
BiotechFrance· 2025
Biomemory
Active
TMTFrance· 2024
Polygon
Polygon
Active
BiotechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Allogenica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Allogenica?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Allogenica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue